A Phase 1/11 Open Label Study Of T138067 - Sodium In Patients With Advanced Surgically Unresectable Hepatocellular Carcinoma

Project Details

Short titleA Phase 1/11 Open Label Study Of T138067 - Sodium In Patients With Advanced Surgically Unresectable Hepatocellular Carcinoma
StatusFinished
Effective start/end date1/02/0131/12/04

Funding

  • TULARIK INC